Skip to content

Observation on the effect of Transmitting Fuzheng Moxibustion in patients with chronic kidney disease stage 3-5

Observation on the effect of Transmitting Fuzheng Moxibustion in patients with chronic kidney disease stage 3-5

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061486
Enrollment
Unknown
Registered
2022-06-26
Start date
2022-06-12
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Control group:Basic treatment of traditional Chinese and western medicine
Experimental group:Basic treatment of traditional Chinese and western medicine+Transmitting Fuzheng Moxibustion

Sponsors

Jiangsu Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. No gender limit, aged 18-75 years; 2. The diagnostic criteria of stage 3-5 chronic kidney disease were met, GFR < 60ml/min, and acute renal failure was excluded; 3. Informed consent and volunteer. The process of obtaining informed consent shall comply with the provisions of GCP.

Exclusion criteria

Exclusion criteria: 1. According to K-DOQI guidelines, patients who cannot be controlled by conservative medical treatment and still present one of the following conditions are excluded: Hb5.5mmol/L; Or high serum creatinine, eGFR<=5ml/min/1.73m^2 (EPI formula conversion); 2. Long-term hemodialysis or peritoneal dialysis patients; 3. Pregnant or lactating patients; 4. Patients with active malignant tumor, severe primary diseases such as decompensated cirrhosis or hematopoietic system, hemorrhagic disease, or mental illness; 5. Patients who are participating in other clinical studies; 6. Those who are known to be allergic to or unable to tolerate one of the drugs in the study; 7. Those who the researchers thought should not be included.

Design outcomes

Primary

MeasureTime frame
Kidney function;Urine protein quantification;Evaluation of main symptoms;

Countries

China

Contacts

Public ContactWei Qiaolan

Jiangsu Hospital of Traditional Chinese Medicine

szyhlwql@sina.com+86 13851785188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026